Regulatory authorities in the European Union (EU) have set up a task force to improve the availability of medicines by mitigating potential shortages based on a two-year roadmap published on Wednesday.
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) organized the task force to achieve five main objectives. These include facilitating the approvals of medicines in the EU, developing strategies for shortages caused by supply chain disruptions, promoting best practices for shortage prevention and improving information-sharing among regulatory authorities.
The fifth priority relates to strengthening the line of communication about issues in the supply of medicines to EU citizens and encouraging greater collaboration among stakeholders. A public workshop will be held on 8-9 November to obtain stakeholder feedback on the task force’s work items.